Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

Robert A. Kyle, S Vincent Rajkumar

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

INTRODUCTION In 1952, Jan Waldenström introduced the term “essential hyperglobulinemia” to describe patients with a small spike in the electrophoretic pattern but no evidence of multiple myeloma (MM), Waldenström macroglobulinemia (WM), amyloidosis (AL), or related disorders. Benign, idiopathic, asymptomatic, nonmyelomatous, cryptogenic, lanthanic, and rudimentary monoclonalgammopathy; dysimmunoglobulinemia; idiopathic paraproteinemia; and asymptomatic paraimmunoglobulinemia have been used to describe the entity. According to Waldenström, the protein spike remained constant in size in contrast to the increasing protein spike of the protein in MM. The entity became known as “benign monoclonal gammopathy,” but this is misleading because a monoclonal (M) protein may remain stable or it may increase and develop into symptomatic MM, WM, AL, or a related disorder. Because of this, the term “monoclonal gammopathy of undetermined significance” is a more appropriate term. Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the proliferation of a single clone of plasma cells that produces a homogeneous monoclonal (M) protein. Each M protein consists of two heavy polypeptide chains of the same class and subclass and two light chain polypeptide chains of the same type. In contrast, polyclonal immunoglobulins are produced by many clones of plasma cells. They contain all heavy chain classes and both light chain types. Each M protein consists of two heavy polypeptide chains of the same class: gamma (γ) constitutes immunoglobulin G (IgG), alpha (α) is found in IgA, mu (μ) is present in IgM, delta (δ) occurs in IgD, and epsilon (ε) is present in IgE.

Original languageEnglish (US)
Title of host publicationTreatment of Multiple Myeloma and Related Disorders
PublisherCambridge University Press
Pages164-181
Number of pages18
Volume9780521515030
ISBN (Print)9780511551901, 9780521515030
DOIs
StatePublished - Jan 1 2008

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Proteins
Waldenstrom Macroglobulinemia
Amyloidosis
Plasma Cells
Peptides
Clone Cells
Light
Immunoglobulin D
Paraproteinemias
Immunoglobulin A
Immunoglobulin E
Immunoglobulin M
Immunoglobulins
Immunoglobulin G

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kyle, R. A., & Rajkumar, S. V. (2008). Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. In Treatment of Multiple Myeloma and Related Disorders (Vol. 9780521515030, pp. 164-181). Cambridge University Press. https://doi.org/10.1017/CBO9780511551901.013

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. / Kyle, Robert A.; Rajkumar, S Vincent.

Treatment of Multiple Myeloma and Related Disorders. Vol. 9780521515030 Cambridge University Press, 2008. p. 164-181.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kyle, RA & Rajkumar, SV 2008, Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. in Treatment of Multiple Myeloma and Related Disorders. vol. 9780521515030, Cambridge University Press, pp. 164-181. https://doi.org/10.1017/CBO9780511551901.013
Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. In Treatment of Multiple Myeloma and Related Disorders. Vol. 9780521515030. Cambridge University Press. 2008. p. 164-181 https://doi.org/10.1017/CBO9780511551901.013
Kyle, Robert A. ; Rajkumar, S Vincent. / Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Treatment of Multiple Myeloma and Related Disorders. Vol. 9780521515030 Cambridge University Press, 2008. pp. 164-181
@inbook{8a8e876d6ec743ed9a36a70c13f96fb4,
title = "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma",
abstract = "INTRODUCTION In 1952, Jan Waldenstr{\"o}m introduced the term “essential hyperglobulinemia” to describe patients with a small spike in the electrophoretic pattern but no evidence of multiple myeloma (MM), Waldenstr{\"o}m macroglobulinemia (WM), amyloidosis (AL), or related disorders. Benign, idiopathic, asymptomatic, nonmyelomatous, cryptogenic, lanthanic, and rudimentary monoclonalgammopathy; dysimmunoglobulinemia; idiopathic paraproteinemia; and asymptomatic paraimmunoglobulinemia have been used to describe the entity. According to Waldenstr{\"o}m, the protein spike remained constant in size in contrast to the increasing protein spike of the protein in MM. The entity became known as “benign monoclonal gammopathy,” but this is misleading because a monoclonal (M) protein may remain stable or it may increase and develop into symptomatic MM, WM, AL, or a related disorder. Because of this, the term “monoclonal gammopathy of undetermined significance” is a more appropriate term. Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the proliferation of a single clone of plasma cells that produces a homogeneous monoclonal (M) protein. Each M protein consists of two heavy polypeptide chains of the same class and subclass and two light chain polypeptide chains of the same type. In contrast, polyclonal immunoglobulins are produced by many clones of plasma cells. They contain all heavy chain classes and both light chain types. Each M protein consists of two heavy polypeptide chains of the same class: gamma (γ) constitutes immunoglobulin G (IgG), alpha (α) is found in IgA, mu (μ) is present in IgM, delta (δ) occurs in IgD, and epsilon (ε) is present in IgE.",
author = "Kyle, {Robert A.} and Rajkumar, {S Vincent}",
year = "2008",
month = "1",
day = "1",
doi = "10.1017/CBO9780511551901.013",
language = "English (US)",
isbn = "9780511551901",
volume = "9780521515030",
pages = "164--181",
booktitle = "Treatment of Multiple Myeloma and Related Disorders",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

AU - Kyle, Robert A.

AU - Rajkumar, S Vincent

PY - 2008/1/1

Y1 - 2008/1/1

N2 - INTRODUCTION In 1952, Jan Waldenström introduced the term “essential hyperglobulinemia” to describe patients with a small spike in the electrophoretic pattern but no evidence of multiple myeloma (MM), Waldenström macroglobulinemia (WM), amyloidosis (AL), or related disorders. Benign, idiopathic, asymptomatic, nonmyelomatous, cryptogenic, lanthanic, and rudimentary monoclonalgammopathy; dysimmunoglobulinemia; idiopathic paraproteinemia; and asymptomatic paraimmunoglobulinemia have been used to describe the entity. According to Waldenström, the protein spike remained constant in size in contrast to the increasing protein spike of the protein in MM. The entity became known as “benign monoclonal gammopathy,” but this is misleading because a monoclonal (M) protein may remain stable or it may increase and develop into symptomatic MM, WM, AL, or a related disorder. Because of this, the term “monoclonal gammopathy of undetermined significance” is a more appropriate term. Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the proliferation of a single clone of plasma cells that produces a homogeneous monoclonal (M) protein. Each M protein consists of two heavy polypeptide chains of the same class and subclass and two light chain polypeptide chains of the same type. In contrast, polyclonal immunoglobulins are produced by many clones of plasma cells. They contain all heavy chain classes and both light chain types. Each M protein consists of two heavy polypeptide chains of the same class: gamma (γ) constitutes immunoglobulin G (IgG), alpha (α) is found in IgA, mu (μ) is present in IgM, delta (δ) occurs in IgD, and epsilon (ε) is present in IgE.

AB - INTRODUCTION In 1952, Jan Waldenström introduced the term “essential hyperglobulinemia” to describe patients with a small spike in the electrophoretic pattern but no evidence of multiple myeloma (MM), Waldenström macroglobulinemia (WM), amyloidosis (AL), or related disorders. Benign, idiopathic, asymptomatic, nonmyelomatous, cryptogenic, lanthanic, and rudimentary monoclonalgammopathy; dysimmunoglobulinemia; idiopathic paraproteinemia; and asymptomatic paraimmunoglobulinemia have been used to describe the entity. According to Waldenström, the protein spike remained constant in size in contrast to the increasing protein spike of the protein in MM. The entity became known as “benign monoclonal gammopathy,” but this is misleading because a monoclonal (M) protein may remain stable or it may increase and develop into symptomatic MM, WM, AL, or a related disorder. Because of this, the term “monoclonal gammopathy of undetermined significance” is a more appropriate term. Monoclonal gammopathy of undetermined significance (MGUS) is characterized by the proliferation of a single clone of plasma cells that produces a homogeneous monoclonal (M) protein. Each M protein consists of two heavy polypeptide chains of the same class and subclass and two light chain polypeptide chains of the same type. In contrast, polyclonal immunoglobulins are produced by many clones of plasma cells. They contain all heavy chain classes and both light chain types. Each M protein consists of two heavy polypeptide chains of the same class: gamma (γ) constitutes immunoglobulin G (IgG), alpha (α) is found in IgA, mu (μ) is present in IgM, delta (δ) occurs in IgD, and epsilon (ε) is present in IgE.

UR - http://www.scopus.com/inward/record.url?scp=78649912380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649912380&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511551901.013

DO - 10.1017/CBO9780511551901.013

M3 - Chapter

SN - 9780511551901

SN - 9780521515030

VL - 9780521515030

SP - 164

EP - 181

BT - Treatment of Multiple Myeloma and Related Disorders

PB - Cambridge University Press

ER -